I recently wrote about the value of HbA1c in measuring more than just our average BG level. And in fact that it’s often not accurate in that. Our best tools for measuring our BG patterns at the moment are Continuous Glucose Monitoring (CGM) systems. Basic data CGM data can show us is how much our …
People often ask me what the secret is to a good closed-loop system and why it works so well for me, and I have to point out that Life is Multi-factorial. I might have some physiological kink that makes it magic for me, but I do think it’s important to both find good technology and …
Varying basals vs ISF, and The Break-Fast Phenomenon Read More »
This is a question we often see discussed, but I think some of those discussions miss an important issue which I’m going to explore here. The HbA1c blood test shows us how much of the haemoglobin in our blood has been “glycated” (bonded with glucose). We’re often shown that value in the context of trying …
The sudden removal of the fast-acting Fiasp insulin from Australia’s PBS subsidy system has been a source of major heartache amongst the diabetes community. But we had a glimmer of hope this morning. The Federal Health Minister (Mark Butler MP) has announced that instead of Fiasp being summarily deleted from PBS, it’s going into “Supply …
How much do we pay for insulin in Australia? Usually in Australia insulin has been available in three formats: 10 mL vials 3 mL pen cartridges (“Penfill” is the name for the Novo cartridges, but the Sanofi and Lilly cartridges have the same capacity) 3 mL disposable pens Using different formats I started off with …
Economics of insulin from a PBS-user perspective Read More »
I have a suspicion about some of the background to the current Fiasp drama, where Novo seems to have been pressured to remove Fiasp from PBS listing. Stories are rarely simple. I don’t know this is the complete story, but I’ll try to stick to recounting known facts! This is a potted history of one …